全文获取类型
收费全文 | 3176篇 |
免费 | 236篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 126篇 |
妇产科学 | 94篇 |
基础医学 | 515篇 |
口腔科学 | 36篇 |
临床医学 | 268篇 |
内科学 | 748篇 |
皮肤病学 | 81篇 |
神经病学 | 392篇 |
特种医学 | 85篇 |
外科学 | 311篇 |
综合类 | 12篇 |
一般理论 | 1篇 |
预防医学 | 203篇 |
眼科学 | 23篇 |
药学 | 221篇 |
中国医学 | 5篇 |
肿瘤学 | 286篇 |
出版年
2024年 | 4篇 |
2023年 | 40篇 |
2022年 | 87篇 |
2021年 | 144篇 |
2020年 | 100篇 |
2019年 | 123篇 |
2018年 | 112篇 |
2017年 | 96篇 |
2016年 | 106篇 |
2015年 | 122篇 |
2014年 | 166篇 |
2013年 | 186篇 |
2012年 | 300篇 |
2011年 | 293篇 |
2010年 | 147篇 |
2009年 | 135篇 |
2008年 | 249篇 |
2007年 | 202篇 |
2006年 | 167篇 |
2005年 | 179篇 |
2004年 | 132篇 |
2003年 | 114篇 |
2002年 | 78篇 |
2001年 | 14篇 |
2000年 | 9篇 |
1999年 | 10篇 |
1998年 | 14篇 |
1997年 | 13篇 |
1996年 | 15篇 |
1995年 | 4篇 |
1994年 | 4篇 |
1993年 | 9篇 |
1992年 | 6篇 |
1991年 | 6篇 |
1990年 | 3篇 |
1988年 | 5篇 |
1987年 | 1篇 |
1986年 | 7篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 1篇 |
1980年 | 3篇 |
1979年 | 1篇 |
1975年 | 1篇 |
1974年 | 2篇 |
1972年 | 1篇 |
1971年 | 2篇 |
1970年 | 2篇 |
1967年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有3427条查询结果,搜索用时 734 毫秒
51.
Vassilis L. Tzounakas Serena I. Valsami Anastasios G. Kriebardis Issidora S. Papassideri Jerard Seghatchian Marianna H. Antonelou 《Transfusion and apheresis science》2018,57(3):347-357
Notwithstanding the high safety level of the currently available blood for transfusion and the decreasing frequency of transfusion-related complications, administration of labile blood products to paediatric patients still poses unique challenges and considerations. The incidence of thalassaemia and sickle cell disease in the paediatric population may be high enough under specific racial and geographical contexts. Red cell transfusion is the cornerstone of β-thalassaemia treatment and one of the most effective ways to prevent or correct specific acute and chronic complications of sickle cell disease. However, this life-saving strategy comes with its own complications, such as additional iron overload, alloimmunization and haemolytic reactions, among others. In paediatrics, the dependency of the transfusion outcome upon disease and other recipient characteristics is more prominent compared with the adults, owing to differences in developmental maturity and physiology that render them more susceptible to common risks, exacerbate the host response to transfused cells, and modify the type or the clinical severity of the transfusion-related morbidity. The adverse branch of red cell transfusion is likely the overall effect of several factors acting synergistically to shape the clinical phenotype of this therapy, including inherent donor/blood unit variables, like antigenicity, red cell deformability and extracellular vesicles, as well as recipient variables, such as history of alloimmunization and inflammation level at time of transfusion. This review focuses on paediatric patients with β-thalassaemia and sickle cell disease as a recipient group with distinct transfusion-related characteristics, and introduces new concepts for consideration, not adequately studied and elucidated so far. 相似文献
52.
Serena L. Orr 《Current pain and headache reports》2018,22(5):37
Purpose of Review
Nutraceuticals are a form of complementary and alternative medicine that is commonly used by children and adolescents with migraine. In this review, observational studies, randomized controlled trials, systematic reviews, and meta-analyses on the efficacy and safety of single compound nutraceuticals for the management of migraine in children and adolescents were identified through a literature search of MEDLINE, Embase, and EBM Reviews—Cochrane Central Register of Controlled Trials.Recent Findings
Twenty-one studies were reviewed, of which 11 were observational studies, 7 were randomized controlled trials, and 3 were systematic reviews. Six different nutraceuticals were included in the review: vitamin D, riboflavin, coenzyme Q10, magnesium, butterbur, and polyunsaturated fatty acids. All but three of the studies assessed the role of nutraceuticals in migraine prevention, while three studies evaluated the role of intravenous magnesium for acute migraine management. Overall, the quality and size of the studies were limited.Summary
Due to low quality evidence and limited studies, no definite conclusions can be drawn on the efficacy of nutraceuticals for the treatment of pediatric migraine. Future studies are warranted in order to establish evidence upon which to define the role of nutraceuticals in this patient population.53.
Development and validation of a risk stratification score for new‐onset atrial fibrillation in STEMI patients undergoing primary percutaneous coronary intervention
下载免费PDF全文
![点击此处可从《International journal of clinical practice》网站下载免费的PDF全文](/ch/ext_images/free.gif)
54.
55.
Transfusion of leukoreduced blood products and risk of antibody‐mediated rejection of renal allografts
下载免费PDF全文
![点击此处可从《Transfusion》网站下载免费的PDF全文](/ch/ext_images/free.gif)
56.
Predictors of First‐Line Treatment Success in Children and Adolescents Visiting an Infusion Center for Acute Migraine
下载免费PDF全文
![点击此处可从《Headache》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Serena L. Orr MD MSc FRCPC Marielle A. Kabbouche MD Paul S. Horn PhD Hope L. O'Brien MD FAHS FAAN Joanne Kacperski MD Susan LeCates MSN APRN CNP Shannon White DNP CNP Jessica Weberding MSN CNP Mimi N. Miller MSN APRN CNP Scott W. Powers PhD ABPP FAHS Andrew D. Hershey MD PhD FAHS 《Headache》2018,58(8):1194-1202
57.
Bastrikova N Gardner GA Reece JM Jeromin A Dudek SM 《Proceedings of the National Academy of Sciences of the United States of America》2008,105(8):3123-3127
A critical component of nervous system development is synapse elimination during early postnatal life, a process known to depend on neuronal activity. Changes in synaptic strength in the form of long-term potentiation (LTP) and long-term depression (LTD) correlate with dendritic spine enlargement or shrinkage, respectively, but whether LTD can lead to an actual separation of the synaptic structures when the spine shrinks or is lost remains unknown. Here, we addressed this issue by using concurrent imaging and electrophysiological recording of live synapses. Slices of rat hippocampus were cultured on multielectrode arrays, and the neurons were labeled with genes encoding red or green fluorescent proteins to visualize presynaptic and postsynaptic neuronal processes, respectively. LTD-inducing stimulation led to a reduction in the synaptic green and red colocalization, and, in many cases, it induced a complete separation of the presynaptic bouton from the dendritic spine. This type of synapse loss was associated with smaller initial spine size and greater synaptic depression but not spine shrinkage during LTD. All cases of synapse separation were observed without an accompanying loss of the spine during this period. We suggest that repeated low-frequency stimulation simultaneous with LTD induction is capable of restructuring synaptic contacts. Future work with this model will be able to provide critical insight into the molecular mechanisms of activity- and experience-dependent refinement of brain circuitry during development. 相似文献
58.
59.
Gianni Gerlini Serena Sestini Paola Di Gennaro Carmelo Urso Nicola Pimpinelli Lorenzo Borgognoni 《Clinical & experimental metastasis》2013,30(1):37-45
Electrochemotherapy (ECT) is a novel treatment for recurrent or in-transit unresectable melanoma metastases based on the administration of anti-neoplastic drugs followed by cancer cell electroporation. Whether ECT can also induce anti-tumour immunity is unclear. We addressed this issue investigating the presence of dendritic cells (DCs) in the inflammatory infiltrate of ECT-treated lesions. Biopsies from melanoma patients (n = 9) were taken before ECT (T0), at d7 and d14 after treatment and studied by immunofluorescence with DCs-related antibodies. Epidermal Langerin+ Langerhans cells (LCs) were the most represented subset before treatment. ECT induced a significant reduction in epidermal LCs number at d7 (p < 0.001), while they were completely replaced at d14. Similarly, the few LCs observed intermingled with metastatic melanoma cells at T0 decreased after treatment (p < 0.001), suggesting an ECT-induced activation of LCs. Consistently, at d1 after ECT (n = 3 patients), LCs were found to express CCR7, which mediates LCs migration to regional lymph nodes, and CD83, the typical DCs maturation marker. In contrast, plasmacytoid DCs (pDCs) were not present at T0, but significantly increased after ECT both in melanoma metastasis (p < 0.001) and perilesionally (p < 0.05). Similarly, CD1c+ dermal DCs (dDCs), observed in low number before ECT, strongly increased at d7 and even more at d14 (p < 0.05 and p < 0.001, respectively). Notably, some dDCs expressed CD83. These data suggest that ECT promotes LCs migration from the tumour to draining lymph nodes and pDCs and dDCs recruitment at the site of the lesion. These findings may help to design new strategies of in situ DCs vaccination in cancer patients. 相似文献
60.
B. Fuentes S. Amaro M. Alonso de Leciñana J.F. Arenillas O. Ayo-Martín M. Castellanos M. Freijo A. García-Pastor M. Gomis M. Gómez Choco E. López-Cancio P. Martínez Sánchez A. Morales E.J. Palacio-Portilla M. Rodríguez-Yáñez J. Roquer T. Segura J. Serena J. Vivancos-Mora 《Neurología (Barcelona, Spain)》2021,36(4):305-323
ObjectiveTo update the Spanish Society of Neurology's guidelines for stroke prevention in patients with type 2 diabetes or prediabetes, analysing the available evidence on the effect of metabolic control and the potential benefit of antidiabetic drugs with known vascular benefits in addition to conventional antidiabetic treatments in stroke prevention.DevelopmentPICO-type questions (Patient, Intervention, Comparison, Outcome) were developed to identify practical issues in the management of stroke patients and to establish specific recommendations for each of them. Subsequently, we conducted systematic reviews of the PubMed database and selected those randomised clinical trials evaluating stroke as an independent variable (primary or secondary). Finally, for each of the PICO questions we developed a meta-analysis to support the final recommendations.ConclusionsWhile there is no evidence that metabolic control reduces the risk of stroke, some families of antidiabetic drugs with vascular benefits have been shown to reduce these effects when added to conventional treatments, both in the field of primary prevention in patients presenting type 2 diabetes and high vascular risk or established atherosclerosis (GLP-1 agonists) and in secondary stroke prevention in patients with type 2 diabetes or prediabetes (pioglitazone). 相似文献